These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

819 related items for PubMed ID: 14983985

  • 1. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD, Santiago LE, Knubson D, Liberatore K, Estronza G, Colón O, Acevedo M.
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [Abstract] [Full Text] [Related]

  • 2. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS.
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [Abstract] [Full Text] [Related]

  • 3. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 4. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B, MANIF 2000 Study Group.
    Antivir Ther; 2005 Sep 12; 10(1):53-61. PubMed ID: 15751763
    [Abstract] [Full Text] [Related]

  • 5. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D.
    BJOG; 2013 Nov 12; 120(12):1534-47. PubMed ID: 23924192
    [Abstract] [Full Text] [Related]

  • 6. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML, Jackson GL, Smith R, Wilson KH.
    Clin Ther; 2007 Apr 12; 29(4):711-6. PubMed ID: 17617294
    [Abstract] [Full Text] [Related]

  • 7. Outpatient pharmacy care and HIV viral load response among patients on HAART.
    Castillo E, Palepu A, Beardsell A, Akagi L, Yip B, Montaner JS, Hogg RS.
    AIDS Care; 2004 May 12; 16(4):446-57. PubMed ID: 15203413
    [Abstract] [Full Text] [Related]

  • 8. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.
    HIV Med; 2006 Mar 12; 7(2):99-104. PubMed ID: 16420254
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR.
    J Infect Dis; 2007 Oct 01; 196(7):1044-52. PubMed ID: 17763327
    [Abstract] [Full Text] [Related]

  • 10. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A, Maiques V, Perales A, Lopez-Aldeguer J.
    Acta Obstet Gynecol Scand; 2009 Oct 01; 88(8):882-7. PubMed ID: 19557554
    [Abstract] [Full Text] [Related]

  • 11. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.
    Clin Infect Dis; 2005 Dec 01; 41(11):1662-70. PubMed ID: 16267741
    [Abstract] [Full Text] [Related]

  • 12. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ, Sabin CA, Youle MS, Kinloch-de Loes S, Lampe FC, Madge S, Cropley I, Johnson MA, Phillips AN.
    J Infect Dis; 2004 Nov 15; 190(10):1860-8. PubMed ID: 15499544
    [Abstract] [Full Text] [Related]

  • 13. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P, Fassino S, Lavagnino L, Orofino G, Morosini P, Picardi A.
    Psychother Psychosom; 2009 Nov 15; 78(4):254-7. PubMed ID: 19468260
    [Abstract] [Full Text] [Related]

  • 14. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study.
    Rathbun RC, Farmer KC, Stephens JR, Lockhart SM.
    Clin Ther; 2005 Feb 15; 27(2):199-209. PubMed ID: 15811483
    [Abstract] [Full Text] [Related]

  • 15. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.
    Antivir Ther; 2004 Jun 15; 9(3):407-14. PubMed ID: 15259903
    [Abstract] [Full Text] [Related]

  • 16. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women.
    Vaz MJ, Barros SM, Palacios R, Senise JF, Lunardi L, Amed AM, Castelo A.
    Int J STD AIDS; 2007 Jan 15; 18(1):28-32. PubMed ID: 17326859
    [Abstract] [Full Text] [Related]

  • 17. Antiretroviral treatment during pregnancy.
    Keiser O, Gayet-Ageron A, Rudin C, Brinkhof MW, Gremlich E, Wunder D, Drack G, Hirschel B, de Tejada BM, Swiss HIV Cohort Study (SHCS), Swiss Mother & Child HIV Cohort Study (MoCHiV).
    AIDS; 2008 Nov 12; 22(17):2323-30. PubMed ID: 18981771
    [Abstract] [Full Text] [Related]

  • 18. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E, Hogg RS, Yip B, Moore D, Harrigan PR, Montaner JS.
    AIDS; 2006 May 12; 20(8):1117-23. PubMed ID: 16691062
    [Abstract] [Full Text] [Related]

  • 19. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun 12; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 20. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.
    McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP.
    Clin Infect Dis; 2001 Sep 01; 33(5):700-5. PubMed ID: 11486292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.